Your browser doesn't support javascript.
loading
Once-weekly (70 mg/m2 ) vs twice-weekly (56 mg/m2 ) dosing of carfilzomib in patients with relapsed or refractory multiple myeloma: A post hoc analysis of the ENDEAVOR, A.R.R.O.W., and CHAMPION-1 trials.
Moreau, Philippe; Stewart, Keith A; Dimopoulos, Meletios; Siegel, David; Facon, Thierry; Berenson, James; Raje, Noopur; Berdeja, Jesus G; Orlowski, Robert Z; Yang, Hui; Ma, Haijun; Klippel, Zandra; Zahlten-Kumeli, Anita; Mezzi, Khalid; Iskander, Karim; Mateos, Maria-Victoria.
Afiliação
  • Moreau P; University Hospital of Nantes, Nantes, France.
  • Stewart KA; Mayo Clinic, Scottsdale, AZ, USA.
  • Dimopoulos M; School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Siegel D; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA.
  • Facon T; Hôpital Claude Huriez, Lille University Hospital, Lille, France.
  • Berenson J; Institute for Myeloma & Bone Cancer Research, West Hollywood, CA, USA.
  • Raje N; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Berdeja JG; Sarah Cannon Research Institute, Nashville, TN, USA.
  • Orlowski RZ; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Yang H; Amgen Inc., Thousand Oaks, CA, USA.
  • Ma H; Amgen Inc., Thousand Oaks, CA, USA.
  • Klippel Z; Amgen Inc., Thousand Oaks, CA, USA.
  • Zahlten-Kumeli A; Amgen Inc., Thousand Oaks, CA, USA.
  • Mezzi K; Amgen Inc., Thousand Oaks, CA, USA.
  • Iskander K; Amgen Inc., Thousand Oaks, CA, USA.
  • Mateos MV; University Hospital Salamanca/IBSAL, Salamanca, Spain.
Cancer Med ; 9(9): 2989-2996, 2020 05.
Article em En | MEDLINE | ID: mdl-32108443
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Resistencia a Medicamentos Antineoplásicos / Mieloma Múltiplo / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Med Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Resistencia a Medicamentos Antineoplásicos / Mieloma Múltiplo / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Med Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França